10/07/25

Ahead of Phacilitate’s Advanced Therapies Europe, Join key industry experts to discuss the current state and trajectory of ATMPs in the EU.

As the world has seen seismic shifts in the funding, technical and commercial landscape for cell and gene therapies, it is important to identify Europe’s evolving role in the global ecosystem, how we can establish and shore-up European bioregions that can translate, develop and manufacture the next generation of ATMPs.

This is a must-attend, plenary-level meeting for translational, technical and commercial cell and gene therapy experts.

door Idalia Dlugosz